Loss of GATA6 – a transcription factor that controls which genes are turned on or off – can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors.
Andrew Flyak, assistant professor in the Department of Microbiology and Immunology in the College of Veterinary Medicine, has been named a 2026 Pew Scholar in the Biomedical Sciences.
Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.
A new single-protein analysis technique gives researchers an unprecedented ability to study scramblases, and could someday be useful in devising new strategies against multiple diseases.
Cornell Prime dots – known as C’ dots – are effective against prostate tumors, according to a new preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.
A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.
The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, according to a new study.
